Crossmark

Complexes of oxoplatin with rhein and ferulic acid ligands as platinum(<scp>iv</scp>) prodrugs with high anti-tumor activity

Crossref DOI link: https://doi.org/10.1039/C9DT04594E

Published Online: 2020

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Tan, Ming-Xiong https://orcid.org/0000-0002-5352-4030
Wang, Zhen-Feng

Qin, Qi-Pin https://orcid.org/0000-0001-9596-4512
Zou, Bi-Qun https://orcid.org/0000-0001-5339-0258
Liang, Hong
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (21761033, 21867017)

Natural Science Foundation of Guangxi Province Province (2018GXNSFBA138021, 2018GXNSFBA281188, 2016GXNSFAA380300)
License Information

Accepted Manuscript valid from 2021-01-08
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

RELATED DATA

: Supplementary Information

IDENTIFIERS

: Ming-Xiong Tan (ORCID)

: Qi-Pin Qin (ORCID)

: Bi-Qun Zou (ORCID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 30 November 2019; Accepted 7 January 2020; Accepted Manuscript published 8 January 2020; Advance Article published 16 January 2020; Version of Record published 5 February 2020